Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor
Article in Biochemical Pharmacology (March 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in Biochemical Pharmacology (March 2024)
Article in Molecular Cancer (March 2024)
Preprint in bioRxiv (February 2024)